Navigation Links
New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinson's Disease Drug Development

SCOTTSDALE, Ariz., Dec. 2 /PRNewswire/ -- MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for Parkinson's disease (PD) therapies. This report, entitled Thought Leader Insight & Analysis -- Parkinson's Disease, is based on 9 interviews conducted with PD experts from the US (6) and Europe (3).

"Regardless of whether they're delivered via surgical implants, gene therapies, viral vectors or old-fashioned small molecules, the most dramatic advances in Parkinson's disease therapeutics will be used in early stage disease to prevent loss of functional status and quality of life," says lead author Dr. Jeffrey D. Berk. "Improvements in invasive procedures and new understanding of the pathophysiology of Parkinson's disease are shifting the risk/benefit ratio and opening up new possibilities for patients."

In addition to discussing today's treatment goals, available therapeutic approaches and unmet needs, MedPredict's expert panel explores the current state of the art in new approaches being developed for the symptomatic treatment and disease modification of PD, including:

    -- Unmet needs: dopamine agonists, wearing off vs. dyskinesia, depression,
       pain, dementia, psychosis, neuroprotection, impulse control (punding),
       restless legs syndrome;
    -- Deep brain stimulation (risk/benefit, pharmacoeconomics);
    -- Gene therapies and growth factors (human fetal implants, GDNF,
       neurturin, neublastin, GAD/glutamic acid decarboxylase),
    -- Dopamine agonists, monoamine oxidase inhibitors;
    -- Levodopa formulations, COMT inhibitors; and
    -- Adenosine A2A receptor antagonists, cholinesterase inhibitors, AMPA,
       5-HT, anticonvulsants, antihypertensives, farnesyl transferase

Companies mentioned in this report include: Acadia, Amersham Pharmacia Biotech/GE Healthcare, Amsterdam Molecular Therapeutics, Bayer-Schering, Bayer-Schering/Titan, Boehringer Ingelheim, Ceregene/Genzyme, Eisai, Elan, Forest, GlaxoSmithKline, GSK/XenoPort/Astellas, Ipsen, Kyowa, Lilly, Link Medicine Corp, Medtronic, Merck-Serono, Merck-Serono/Newron, NeuroDerm, Neurologix, Novartis, NsGene, Ortho-McNeill-Janssen, Pfizer, Qrx Pharma, Schering-Plough, Solvay, Solvay/Wyeth, Teva, UCB, Valeant, and Wyeth.

This report can be purchased by contacting MedPredict (

About MedPredict

MedPredict maintains a proprietary database of over 1,000 global physician thought leaders, including 40+ specialties in 30+ therapeutic categories. Based on primary interviews with these thought leaders, MedPredict publishes periodic reports in each category to keep clients up-to-date on emerging trends and competitive activity. The reports include thought leader reactions to recent publications and medical conferences, as well as clinical, regulatory and marketing activity.

SOURCE MedPredict
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
2. European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTrends Report
3. The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance
4. Encorium Reports Third Quarter 2008 Financial Results
5. Interim Report for the Period 1 January - 30 September 2008 (Unaudited)
6. NSD Bio Group, LLC chosen by U.S.-China Economic & Security Review Commission for Report on Chinas High Tech Sectors
7. Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results
8. SPO Medical Reports Nine Month Period Ending September 2008
9. Sinovac Reports Third Quarter 2008 Unaudited Financial Results
10. Benda Pharmaceutical Reports Third Quarter 2008 Financial Results
11. Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica ... on AngelList early in their initial angel funding process. Now, they are paying ... looking to make early stage investments in the microbiome space. In this, ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... healthy metabolism. But unless it is bound to proteins, copper is also toxic ... (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic study of ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
Breaking Biology Technology:
(Date:11/19/2015)... Nov. 19, 2015  Although some 350 companies are ... by a few companies, according to Kalorama Information. These include ... of the market share of the 6.1 billion-dollar molecular ... World Market for Molecular Diagnostic s .    ... is still controlled by one company and only a ...
(Date:11/18/2015)... 18, 2015 --> ... new market report titled  Gesture Recognition Market - Global ... - 2021. According to the report, the global gesture recognition market was ... to reach US$29.1 bn by 2021, at a CAGR ... North America dominated the global gesture recognition ...
(Date:11/17/2015)... Paris , qui s,est tenu ... Paris , qui s,est tenu du 17 au ... l,innovation biométrique, a inventé le premier scanner couplé, qui ... même surface de balayage. Jusqu,ici, deux scanners étaient nécessaires, ... digitales. Désormais, un seul scanner est en mesure de ...
Breaking Biology News(10 mins):